We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+21.48%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$21.4B
AUM Growth
+$2.83B
(+15%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
7.78%
Top 10 Holdings %
Top 10 Hldgs %
10.34%
Holding
1,926
New
598
Increased
490
Reduced
463
Closed
369
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$180M |
| 2 |
Walmart Inc
WMT
|
+$154M |
| 3 |
McDonald's
MCD
|
+$143M |
| 4 |
Hartford Financial Services
HIG
|
+$143M |
| 5 |
Citigroup
C
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$153M |
| 2 |
Advance Auto Parts
AAP
|
+$131M |
| 3 |
Wells Fargo
WFC
|
+$130M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$116M |
| 5 |
Abbott
ABT
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.48% |
| 2 | Consumer Discretionary | 12.21% |
| 3 | Healthcare | 8.51% |
| 4 | Technology | 7.64% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
MPLX
MPLX
$61.3B
| $13.1M | 0.06% |
361,947
-138,053
| -28% | -$5.09M |
|
402
CONMED
CNMD
$1.49B
| $13M | 0.06% |
+293,407
| New | +$12.6M |
|
403
Sarepta Therapeutics
SRPT
$1.77B
| $13M | 0.06% |
439,245
+255,602
| +139% | +$7.91M |
|
|
ANDX
404
DELISTED
Andeavor Logistics LP
ANDX
| $13M | 0.06% |
238,152
-288,384
| -55% | -$16M |
|
405
Tronox
TROX
$1.11B
| $12.9M | 0.06% |
+700,521
| New | +$10.4M |
|
406
Howard Hughes
HHH
$4.06B
| $12.9M | 0.06% |
+115,380
| New | +$12.4M |
|
407
Assured Guaranty
AGO
$3.66B
| $12.9M | 0.06% |
347,085
+152,908
| +79% | +$6.06M |
|
|
ETP
408
DELISTED
Energy Transfer Partners, L.P.
ETP
| $12.8M | 0.06% |
525,838
+161,260
| +44% | +$4.02M |
|
409
Biogen
BIIB
$30.5B
| $12.7M | 0.06% |
46,616
-48,210
| -51% | -$13.6M |
|
|
VAR
410
DELISTED
Varian Medical Systems, Inc.
VAR
| $12.7M | 0.06% |
139,712
+126,484
| +956% | +$10.5M |
|
411
Steven Madden
SHOO
$3.53B
| $12.7M | 0.06% |
493,623
+467,458
| +1,787% | +$11.4M |
|
412
O'Reilly Automotive
ORLY
$76.2B
| $12.7M | 0.06% |
705,165
+657,045
| +1,365% | +$11.9M |
|
413
Morgan Stanley
MS
$336B
| $12.7M | 0.06% |
295,637
+189,580
| +179% | +$8.41M |
|
|
MXIM
414
DELISTED
Maxim Integrated Products
MXIM
| $12.6M | 0.06% |
281,217
+159,432
| +131% | +$6.99M |
|
415
Madison Square Garden
MSGS
$9.43B
| $12.6M | 0.06% |
88,525
-181,246
| -67% | -$23.6M |
|
416
Dave & Buster's
PLAY
$351M
| $12.6M | 0.06% |
+205,691
| New | +$11.7M |
|
417
Hilton Grand Vacations
HGV
$3.61B
| $12.6M | 0.06% |
+438,416
| New | +$12.5M |
|
|
QTS
418
DELISTED
QTS REALTY TRUST, INC.
QTS
| $12.5M | 0.06% |
257,389
+112,786
| +78% | +$5.66M |
|
419
CALL
PayPal
PYPL
$51.1B
| $12.5M | 0.06% |
+290,000
| New | +$12.1M |
|
|
EVHC
420
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $12.5M | 0.06% |
203,292
-361,630
| -64% | -$24.2M |
|
421
Edwards Lifesciences
EW
$51.5B
| $12.5M | 0.06% |
397,188
-1,026,360
| -72% | -$32.1M |
|
422
CALL
Lowe's Companies
LOW
$122B
| $12.3M | 0.06% |
+150,000
| New | +$11.5M |
|
423
Wynn Resorts
WYNN
$10.5B
| $12.3M | 0.06% |
+107,486
| New | +$10.7M |
|
424
Medtronic
MDT
$110B
| $12.2M | 0.06% |
151,704
-325,176
| -68% | -$25.4M |
|
425
Ventas
VTR
$47.3B
| $12.2M | 0.06% |
+187,200
| New | +$11.7M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Balyasny Asset Management held 1,926 positions worth $21.4B, up 15% from $18.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Balyasny Asset Management deployed $1.67B of net new capital in Q1 2017, opening 598 new positions and adding to 490 existing holdings. Its largest new stake was Citigroup: 2,292,111 shares worth $137M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $153M trimmed.
- Balyasny Asset Management's largest Q1 2017 buy was Citigroup: 2,292,111 shares worth $137M.
- Balyasny Asset Management added most to Vulcan Materials in Q1 2017, an estimated $180M increase.
- Balyasny Asset Management's biggest Q1 2017 reduction was Freeport-McMoran, cutting an estimated $153M.
- Balyasny Asset Management fully exited Coterra Energy in Q1 2017, selling an estimated $116M.
- Balyasny Asset Management's ten largest holdings make up 10% of its $21.4B portfolio in Q1 2017.
- Balyasny Asset Management opened 598 new positions and closed 369 in Q1 2017.
- Balyasny Asset Management's portfolio value rose 15% quarter-over-quarter to $21.4B.
Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.